Symbiotic Healthcare develops FMT pill for C. diff infection

Symbiotic Healthcare, based in Manhattan, N.Y., has developed a capsule containing the processed fecal matter used in the C. difficile treatment fecal microbiota transplantation, according to a Crain’s New York Business report.

Advertisement

Symbiotic Healthcare was founded by North Shore-LIJ Health System infectious disease specialist Bruce Hirsch, MD, and immunologist Gerard Honig. The company’s capsule holds the processed matter and can be refrigerated for later use.

In a preliminary test including 23 patients, the pills resulted in an 87 percent cure rate.

The company is currently self-funded, but its founders are looking for financial backing, according to the report.

More Articles on Gastroenterology:
Hiring & firing: what gastroenterologists need to know about finding a stellar staff
Are C. diff infections on the move?
PPI is 3rd most-prescribed drug in the U.S.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.